Products Cited in Publications Worldwide Chemical inhibition of a bacterial immune system

Chemical inhibition of a bacterial immune system

Zang, Zhiyu; Duncan, Olivia K; Sabonis, Dziugas; Shi, Yun; Miraj, Gause; Fedorova, Iana; Le, Shuai; Deng, Jun; Zhu, Yuhao; Cai, Yanyao

DOI:

Abstract

The rise of antibiotic resistance motivates a revived interest in phage therapy. However, bacteria possess dozens of anti-bacteriophage immune systems that confer resistance to therapeutic phages. Chemical inhibitors of these anti-phage immune systems could be employed as adjuvants to overcome resistance in phage-based therapies. Here, we report that anti-phage systems can be selectively inhibited by small molecules, thereby sensitizing phage-resistant bacteria to phages. We discovered a class of chemical inhibitors that inhibit the type II Thoeris anti-phage immune system. These inhibitors block the biosynthesis of a histidine-ADPR intracellular ‘alarm’ signal by ThsB and prevent ThsA from arresting phage replication. These inhibitors promiscuously inhibit type II Thoeris systems from diverse bacteria—including antibiotic-resistant pathogens. Chemical inhibition of the Thoeris defense improved the efficacy of a model phage therapy against a phage-resistant strain of P. aeruginosa in a mouse infection, suggesting a therapeutic potential. Furthermore, these inhibitors may be employed as chemical tools to dissect the importance of the Thoeris system for phage defense in natural microbial communities.

Purchased from AmBeed

Isonicotinamide

A1543651453-82-398%

Isonicotinamide

35.0/100g

Detail

A175137116568-17-395%

1H-Benzo[d]imidazole-6-carboxamide

41.0/250mg

Detail
Picolinamide

A2265581452-77-398%

Picolinamide

18.0/25g

Detail

A52501339031-44-297%

Imidazo[1,2-a]pyridine-2-carboxamide

142.0/250mg

Detail

A8774165382-43-495%

Quinoline-6-carboxamide

19.0/250mg

Detail